Syntune

Syntune is a precision medicine and AI-driven biotechnology company focused on optimizing drug discovery and development for oncology. The company utilizes a proprietary machine learning platform to predict drug responses and identify optimal therapeutic combinations based on multi-omic data. By integrating high-throughput screening with advanced computational models, Syntune aims to accelerate the identification of biomarkers and the development of personalized treatment strategies. Their current focus includes the discovery of novel small molecules and the repurposing of existing therapies for specific cancer patient populations.